(Q34579842)

3 August 2017

3 references

8 April 2021

9 April 2021

Global measles elimination (English)

1 reference

3 August 2017

1 reference

immunization programs

1 reference

8 April 2021

1 reference

9 April 2021

2

Diane E Griffin

1 reference

3 August 2017

1

William J Moss

1 reference

3 August 2017

language of work or name

English

0 references

publication date

6 November 2006

1 reference

Nature Reviews Microbiology

3 August 2017

1 December 2006

2 references

8 April 2021

9 April 2021

3 references

3 August 2017

8 April 2021

9 April 2021

4

1 reference

3 August 2017

900-908

1 reference

3 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro1550

3 August 2017

0 references

cites work

Propagation in tissue cultures of cytopathogenic agents from patients with measles

2 references

https://api.crossref.org/works/10.1038%2FNRMICRO1550

21 January 2018

12 December 2020

Differential CD4 T cell activation in measles.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Epidemiologic basis for eradication of measles in 1967.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

New measles genotype, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Vaccine-associated measles pneumonitis in an adult with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Should measles be eradicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Inapparent measles after gamma globulin administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles-associated diarrhea in hospitalized children in Lima, Peru: pathogenic agents and impact on growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles: not just another viral exanthem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Cellular immune responses during complicated and uncomplicated measles virus infections of man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Changes in plasma IgE levels during complicated and uncomplicated measles virus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Mechanism of suppression of cell-mediated immunity by measles virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Natural Measles Causes Prolonged Suppression of Interleukin‐12 Production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Public-health impact of accelerated measles control in the WHO African Region 2000-03.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles eradication: is it in our future?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles endemicity in insular populations: Critical community size and its evolutionary implication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

The challenges and strategies for laboratory diagnosis of measles in an international setting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Genetic variability of measles virus in acute and persistent infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Update on the Global Distribution of Genotypes of Wild Type Measles Viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Genetic analysis of measles viruses isolated in the united states between 1989 and 2001: absence of an endemic genotype since 1994.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

An epidemic of measles in southern Greenland, 1951; measles in virgin soil. II. The epidemic proper

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Persistent measles infection in malnourished children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Implications of the human immunodeficiency virus epidemic for control and eradication of measles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

First 5 years of measles elimination in southern Africa: 1996-2000.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Variation in vaccine response in normal populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Secondary failure rates of measles vaccines: a metaanalysis of published studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Cost-effectiveness of three different vaccination strategies against measles in Zambian children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Communicable diseases in complex emergencies: impact and challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Polio--new challenges in 2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Individual and community risks of measles and pertussis associated with personal exemptions to immunization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Communicating science to the public: MMR vaccine and autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles outbreaks in a population with declining vaccine uptake.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

MMR vaccine and autism: an update of the scientific evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

A population-based study of measles, mumps, and rubella vaccination and autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

The development of a plant-based vaccine for measles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles vaccines and the potential for worldwide eradication of measles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles elimination: progress and challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Following in the footsteps of smallpox: can we achieve the global eradication of measles?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

The progress of the Polio Eradication Initiative: what prospects for eradicating measles?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Polio eradication and measles immunisation in Nigeria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles virus glycoproteins: studies on the structure and interaction of the haemagglutinin and fusion proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Efficiency of measles virus entry and dissemination through different receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

CD46- and CD150-independent endothelial cell infection with wild-type measles viruses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

The assembly of the measles virus nucleoprotein into nucleocapsid-like particles is modulated by the phosphoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

V and C proteins of measles virus function as virulence factors in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Measles virus and immunomodulation: molecular bases and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1550

Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

31 March 2020

1 reference

12 December 2020

Progress in reducing global measles deaths, 1999-2004.

1 reference

12 December 2020

Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo.

1 reference

12 December 2020

Alterations in Immune Responsiveness in Acute Measles and Chronic Post-Measles Chest Disease

1 reference

12 December 2020

Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren

1 reference

12 December 2020

Evaluating the impact of the HIV pandemic on measles control and elimination.

1 reference

12 December 2020

Circulating vaccine-derived polioviruses: current state of knowledge

1 reference

12 December 2020

Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains

1 reference

12 December 2020

Disturbances in gamma globulin synthesis as experiments of nature

1 reference

12 December 2020

Factors associated with fatal cases of measles. A retrospective autopsy study

1 reference

12 December 2020

Strategies for reducing global measles mortality

1 reference

12 December 2020

Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC

1 reference

12 December 2020

Eradication of poliomyelitis in countries affected by conflict

1 reference

12 December 2020

Can measles be eradicated globally?

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO1550

1 reference

Dimensions Publication ID

3 August 2017

0 references

0 references

1 reference